Hyperlipidemia drugs Flashcards

1
Q

cholesterol drug classes that affect exogenous pathway?

A

bile acid resins

transport inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cholesterol drug classes that affect endogenous pathway?

A

statins
fibric acid
acid- niacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bile acid resin drugs?

A

cholestyramine

colestipol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cholestyramine/colestipol MOA

A

bind negatively-charged bile acids in small intestine-forming insoluble complex excreted in feces
loss of bile acids leads to increase in LDL uptake receptors–>reduced plasma cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cholestyramine/colestipol TOX

A

increase TG levels in first few weeks
bad taste-like drinking sand
bloating
constipation/steatorrhea, anal leakage/fissures
impairment of other drug and fat soluble vitamin absorption
decrease LDL, slight increase of HDL, TG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ezetimibe MOA

A

class: transport inhibitor
prevent cholesterol reabsorbtion at small intestine brush border
additive decrease in LDL when used with statins
little effect on HDL/TG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ezetimibe TOX

A

Rare hepatic toxicity
drug interaction with cyclosporine
elevated transaminases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HMG CoA reductase (statins) MOA

A

inhibit HMG CoA reductase which catalyzes the conversion of acetyl CoA to melvonic acid
liver increases LDL receptors in response to low hepatic cholesterol causing increased reuptake
anti-inflammatory by reducing c reactive protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HMG CoA reductase (statins) Uses

A

preferred lipid lowering drug

decrease LDL. TG, increase HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HMG CoA reductase (statins) TOX

A

hepatotoxicity-check liver enzymes
rhabdomyolysis- myopathy rare but life threatening
contraindicated with CYP450 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

deciding between older and newer statins?

A

older- cheaper, safer, more reliable

newer- more potent and efficacious, decrease LDL with smaller dose to minimize SEs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Niacin MOA

A

inhibition of VLDL secretion into circulation

inhibits lipolysis in adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Niacin USE

A

most effective drug for increasing HDL

reduction in LDL and TG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Niacin TOX

A
only acid form is active- need to check vitamin OTC
intense flushing and pruritis
nausea, abd pain
hyperuricemia
hyperglycemia
hepatotoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fibrates?

A

GEMFIBROZIL
CLOFIBRATE
bezafibrate
fenofibrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

fibrate MOA

A

enhance lipoprotein lipase, increasing TG clearance
decrease fatty acid synthesis
stimulates synthesis of apoA1 which increases HDL

17
Q

fibrate use

A

DECREASE TG

minor decrease LDL and increase HDL

18
Q

fibrate TOX

A

myositis-worse with statins
hepatotoxicity
cholesterol gallstones

19
Q

Rules for lipid treatment

A

rule out secondary dyslipidemia from:
diabetes, hypothyroid, obstructive liver disease, chronic renal failure
know target levels for individualized patients with other conditions
use COMBO therapies for resistant lipid profiles